Literature DB >> 11311638

Pigment dispersion with elevated intraocular pressure after AcrySof intraocular lens implantation in the ciliary sulcus.

R Wintle1, M Austin.   

Abstract

A 45-year-old white woman had phacoemulsification with intraocular lens (IOL) implantation. The surgery was routine except for a linear tear in the posterior capsule; there was no disruption of the anterior vitreous face. After residual soft lens matter was removed, an AcrySof IOL was placed in the ciliary sulcus. One month postoperatively, the patient presented with an intraocular pressure (IOP) of 30 mm Hg and signs of pigment dispersion with 360 degrees of heavy pigmentation of the trabecular meshwork and iris transillumination defects. Intraocular pressure was controlled with a topical beta-blocker. The optic disc appearance and visual field remained normal, but the uniocular hyperpigmentation of the trabecular meshwork was still present. We hypothesize that the sharp square edge of the AcrySof IOL increases the risk of a chafing effect on the posterior iris pigment and advocate that this IOL be placed in the capsular bag and ideally have 360 degrees of protective overlapping of the anterior capsule over the edge of the optic.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11311638     DOI: 10.1016/s0886-3350(00)00792-6

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  12 in total

1.  [Secondary increase in intraocular pressure after complication-free cataract operation with implantation of the posterior chamber lens].

Authors:  D Kook; T Kohnen
Journal:  Ophthalmologe       Date:  2009-02       Impact factor: 1.059

2.  Pathologic assessment of complications with asymmetric or sulcus fixation of square-edged hydrophobic acrylic intraocular lenses.

Authors:  Kevin R Kirk; Liliana Werner; Ryan Jaber; Susan Strenk; Lawrence Strenk; Nick Mamalis
Journal:  Ophthalmology       Date:  2012-03-15       Impact factor: 12.079

3.  Intraocular lens explantation in Chinese patients: different patterns and different responses.

Authors:  Tommy C Y Chan; Jerry K H Lok; Vishal Jhanji; Victoria W Y Wong
Journal:  Int Ophthalmol       Date:  2014-09-03       Impact factor: 2.031

4.  Stability and safety of MA50 intraocular lens placed in the sulcus.

Authors:  A Sandhu; J Clarke
Journal:  Eye (Lond)       Date:  2016-05-13       Impact factor: 3.775

5.  Stability and safety of MA50 intraocular lens placed in the sulcus.

Authors:  P S Kemp; T A Oetting
Journal:  Eye (Lond)       Date:  2015-07-03       Impact factor: 3.775

6.  Management of sulcus-fixated single-piece intraocular lens-induced pigmentary glaucoma with 3-piece IOL exchange.

Authors:  Hossein Mohammad Rabie; Hamed Esfandiari; Mohammad Hassan Rikhtegar; Vahid Hekmat
Journal:  Int Ophthalmol       Date:  2017-01-04       Impact factor: 2.031

7.  Pathologic comparison of asymmetric or sulcus fixation of 3-piece intraocular lenses with square versus round anterior optic edges.

Authors:  Andrew Ollerton; Liliana Werner; Susan Strenk; Lawrence Strenk; Lisa Leishman; Zachary Bodnar; Kevin R Kirk; Jennifer Michelson; Nick Mamalis
Journal:  Ophthalmology       Date:  2013-04-16       Impact factor: 12.079

8.  Novel observations and potential applications using digital infrared iris imaging.

Authors:  Daniel K Roberts; Ana S Lukic; Yongyi Yang; Sayoko E Moroi; Jacob T Wilensky; Miles N Wernick
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2009 Mar-Apr

9.  Late-onset secondary pigmentary glaucoma following foldable intraocular lenses implantation in the ciliary sulcus: a long-term follow-up study.

Authors:  Shirley Hl Chang; Wei-Chi Wu; Shiu-Chen Wu
Journal:  BMC Ophthalmol       Date:  2013-06-07       Impact factor: 2.209

10.  Intermediate term follow-up after a single-piece-acrylic intraocular lens implantation in the ciliary sulcus- a cross-sectional study.

Authors:  Shai M Bar-Sela; Efrat Fleissig
Journal:  BMC Ophthalmol       Date:  2013-12-09       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.